Quest Diagnostics (DGX) Net Income towards Common Stockholders Growth (1y) (2010 - 2026)
Powered by 
Analysis
Quest Diagnostics (DGX) Net Income towards Common Stockholders Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | 33.71% |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 12.89% |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 25.51% |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | -20.26% |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | 119.85% |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | 99.88% |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 573.74% |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 3,367.34% |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | 36.67% |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | 97.32% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.89% |
| Mar 31, 2026 | 19.82% |
| Dec 31, 2025 | 7.79% |
| Sep 30, 2025 | 8.66% |
| Jun 30, 2025 | 19.58% |
| Mar 31, 2025 | 8.50% |
| Dec 31, 2024 | 17.26% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | -0.83% |
| Mar 31, 2024 | -5.66% |
| Dec 31, 2023 | 74.34% |
| Sep 30, 2023 | -14.44% |
| Jun 30, 2023 | -1.63% |
| Mar 31, 2023 | -38.01% |
| Dec 31, 2022 | -70.88% |
| Sep 30, 2022 | -46.11% |
| Jun 30, 2022 | -61.56% |
| Mar 31, 2022 | -27.70% |
| Dec 31, 2021 | -31.57% |
| Sep 30, 2021 | -13.02% |